Clinical Trial Update: JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study [NA]

View source ↗

Summary

Clinical trial update for the JenaValve EFS trial in pericardial TAVR for aortic stenosis; status unknown with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis
• Cardiovascular Diseases
• Heart Diseases
• Heart Valve Diseases
• Ventricular Outflow Obstruction

Drugs mentioned

• JenaValve

Snippet

Sponsor: JenaValve Technology, Inc. | Conditions: Aortic Valve Stenosis, Heart Valve Diseases | NA | Status: UNKNOWN | Results posted: 2022-11-22